(Q40181500)

18 September 2017

Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models (English)

1 reference

18 September 2017

1 reference

Simon P Quenneville

1

1 reference

18 September 2017

Pierre Chapdelaine

2

1 reference

18 September 2017

Daniel Skuk

3

1 reference

18 September 2017

Matin Paradis

4

1 reference

18 September 2017

Marlyne Goulet

5

1 reference

18 September 2017

Joël Rousseau

6

1 reference

18 September 2017

Xiao Xiao

7

1 reference

18 September 2017

Luis Garcia

8

1 reference

18 September 2017

Jacques P Tremblay

9

1 reference

18 September 2017

1 February 2007

1 reference

18 September 2017

1 reference

18 September 2017

15

1 reference

18 September 2017

2

1 reference

18 September 2017

431-438

1 reference

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

18 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Cellular and molecular regulation of muscle regeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Defective myoblasts identified in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Efficient non-viral DNA-mediated gene transfer to human primary myoblasts using electroporation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Transfection of large plasmids in primary human myoblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Telomerase allows the immortalization of T antigen-positive DMD myoblasts: a new source of cells for gene transfer application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Establishment of long-term myogenic cultures from patients with Duchenne muscular dystrophy by retroviral transduction of a temperature-sensitive SV40 large T antigen.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

SV40 Large T Antigen Interferes with Adult Myosin Heavy Chain Expression, but Not with Differentiation of Human Satellite Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Long-term self-renewal of postnatal muscle-derived stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

T-antigen regulated expression reduces apoptosis of tag-transformed human myoblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Myogenic potential of adipose-tissue-derived cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Muscle-derived stem cells: implications for effective myoblast transfer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Genetic complementation between mutant b subunits in F1F0 ATP synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300047

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300047

1 reference

18 September 2017

1 reference